Factor VIII deficiency
Not recruitingStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
- Disease:Factor VIII deficiency
- Substances:Efanesoctocog Alfa
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Efanesoctocog Alfa
- Sponsor:Swedish Orphan Biovitrum AB (publ)













